A negative Cologuard test means the analysis did not detect abnormal DNA or blood in your stool sample. In practical terms, no signs of colorectal cancer or precancerous growths (called advanced adenomas) were found. For most people at average risk, this is reassuring news, but it’s worth understanding what the test actually checked for and what a negative result can and can’t guarantee.
What the Test Looked For
Cologuard analyzes your stool sample for 11 different molecular markers split into three categories. The first checks for DNA changes tied to abnormal cell growth, specifically alterations in how certain genes are switched on or off. The second looks for specific mutations in a gene commonly involved in colorectal cancers. The third component isn’t DNA-based at all. It uses antibodies to detect hemoglobin, the protein in blood, because polyps and cancers sometimes bleed in amounts too small to see with the naked eye.
When your result comes back negative, it means none of these markers crossed the detection threshold. No abnormal DNA fragments from polyp or cancer cells were found in your stool, and no hidden blood was detected.
How Reliable a Negative Result Is
Cologuard has a false negative rate of roughly 8%, meaning about 8 out of every 100 people who actually do have cancer or significant precancerous changes will receive a negative result. That’s a strong detection rate overall, but it’s not perfect. The test is better at catching actual cancer than it is at catching precancerous polyps. Polyps that haven’t yet turned cancerous may not shed enough abnormal DNA or blood into the stool to trigger a positive result.
This is the key distinction between Cologuard and a colonoscopy. A colonoscopy lets a doctor visually inspect the entire colon and remove polyps on the spot. Cologuard relies on indirect signals, fragments and traces that abnormal tissue leaves behind. If a polyp isn’t bleeding and isn’t shedding much DNA, the test can miss it entirely. A negative result lowers the probability that something concerning is present, but it doesn’t eliminate it the way a clean colonoscopy does.
What Happens Next
After a negative result, the current recommendation is to repeat the test every one to three years. Cologuard is designed for ongoing screening, not a one-time check. Colorectal cancer typically develops slowly from polyps over a period of years, so regular retesting gives you multiple chances to catch something early even if one round misses it.
The test is intended for adults aged 45 to 75 who are at average risk, meaning no personal history of colorectal cancer, inflammatory bowel disease, or inherited conditions like Lynch syndrome that significantly raise cancer risk. If you fall into a higher-risk category, your screening plan will likely look different and may center on colonoscopy instead.
Symptoms That Still Deserve Attention
A negative Cologuard result doesn’t explain away symptoms you’re already experiencing. If you have rectal bleeding, unexplained weight loss, persistent changes in bowel habits, or ongoing abdominal pain, those symptoms warrant further evaluation regardless of what a stool test shows. Cologuard is a screening tool built for people without symptoms. It’s not designed to diagnose the cause of symptoms you can already feel. In those situations, a colonoscopy or other direct imaging gives a much more complete picture of what’s happening inside the colon.
Putting the Result in Context
A negative Cologuard result is good news for the vast majority of people who receive one. It means the most common molecular signatures of colorectal cancer and precancerous growths weren’t present in your sample. The 8% false negative rate is real but relatively low, and repeating the test on schedule significantly reduces the chance of anything slipping through undetected over time. Think of it less as a definitive all-clear and more as one data point in an ongoing screening routine. Each negative result adds to your confidence, especially when combined with staying on the recommended retesting schedule.